Stock Price
70.69
Daily Change
-0.02 -0.03%
Monthly
-14.03%
Yearly
-9.58%
Q1 Forecast
68.59

Date Reference Time Actual Consensus Previous
2026-05-11 FY2026Q1 PM 1.08 1.20
2026-02-11 FY2025Q4 PM 0.80 0.83 0.97
2025-11-04 FY2025Q3 PM 1.05 1.02 1.04
2025-08-05 FY2025Q2 PM 1.15 1.12 1.16
2025-05-06 FY2025Q1 PM 1.20 1.12 1.13



Peers Price Chg Day Year Date
Albemarle 175.70 -5.69 -3.14% 135.05% Mar/26
Air Products & Chemicals 294.34 4.25 1.47% -0.26% Mar/26
Ashland 54.10 0.49 0.91% -9.46% Mar/26
Axalta Coating Systems 27.20 -0.46 -1.66% -17.85% Mar/26
Conagra Foods 15.22 -0.10 -0.65% -42.48% Mar/26
Celanese 61.94 -0.72 -1.15% 6.16% Mar/26
CF Industries 132.01 3.90 3.04% 69.29% Mar/26
Church & Dwight 93.38 -1.00 -1.06% -13.85% Mar/26
Colgate-Palmolive 84.57 -0.92 -1.08% -9.25% Mar/26
Clorox 102.47 -2.29 -2.19% -29.64% Mar/26

Indexes Price Day Year Date
US500 6495 -96.58 -1.47% 14.08% Mar/26

International Flavors Fragrances traded at $70.72 this Thursday March 26th, increasing $0.01 or 0.01 percent since the previous trading session. Looking back, over the last four weeks, International Flavors Fragrances gained 14.00 percent. Over the last 12 months, its price fell by 9.54 percent. Looking ahead, we forecast International Flavors Fragrances to be priced at 68.59 by the end of this quarter and at 62.60 in one year, according to Trading Economics global macro models projections and analysts expectations.

International Flavors & Fragrances Inc. offers sensory, food and beverage, pharmaceutical, health and wellness, home and personal care solutions and ingredients. It operates through segments such as Nourish, Scent, Health & Biosciences, and Pharma Solutions. The Nourish segment consists portfolio of natural-based ingredients to improve nutritional value, texture and functionality in a range of beverage, dairy, bakery, confectionery and culinary applications. The Scent segment consists of its legacy Scent segment as well as its Flavor Ingredients business. The Health & Biosciences segment includes a biotechnology-driven probiotics portfolio, that produces cultures for use in fermented foods such as yogurt, cheese and fermented beverages. The Pharma Solutions segment consists of cellulosics and alginates-based pharma excipients.